Liver and Pancreas Surgical Unit, Department of Surgery, The Ottawa Hospital, University of Ottawa, Ottawa, ON, Canada.
Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.
Ann Surg Oncol. 2022 Nov;29(12):7592-7602. doi: 10.1245/s10434-022-12041-x. Epub 2022 Jun 25.
Perihilar cholangiocarcinoma (PHC) is a rare malignancy that arises at the biliary confluence. Achieving a margin-negative resection (R0) is challenging given the anatomic location of tumors and remains the most important prognostic indicator of long-term survival. The objective of this study is to review the impact of intraoperative revision of positive biliary margins in PHC on oncologic outcomes.
Electronic databases were searched from inception to October 2021. Studies comparing three types of patients undergoing resection of PHC with intraoperative frozen section of the proximal and/or distal bile ducts were identified: those who were margin-negative (R0), those with an initially positive margin who had revised negative margins (R1R0), and those with a persistently positive margin with or without revision of a positive margin (R1). The primary outcome was overall survival (OS). Secondary outcomes included risk of postoperative complication.
A total of 449 studies were screened. Ten retrospective observational studies reporting on 1955 patients were included. Patients undergoing successful revision of a positive proximal and/or distal bile duct margin (R1R0) had similar OS to those with a primary margin-negative resection (R0) [hazard ratio (HR) 0.93, 95% confidence interval (CI) 0.72-1.19, p = 0.56, I = 84%], and significantly better OS than patients with a positive final bile duct margin (R1) (HR 0.52, 95% CI 0.34-0.79, p = 0.002, I = 0%). There was no increase in the risk of postoperative complications associated with additional resection, although postoperative morbidity was inconsistently reported.
This review supports routine intraoperative biliary margin evaluation during resection of PHC with revision if technically feasible.
肝门部胆管癌(PHC)是一种罕见的恶性肿瘤,发生在胆管汇合处。由于肿瘤的解剖位置,实现阴性切缘(R0)的切除具有挑战性,并且仍然是长期生存的最重要预后指标。本研究的目的是回顾分析 PHC 术中修正阳性胆管切缘对肿瘤学结果的影响。
从创建到 2021 年 10 月,电子数据库进行了搜索。确定了比较三种接受 PHC 切除术的患者的研究:切缘阴性(R0)、最初切缘阳性但修正为阴性切缘(R1R0)和持续阳性切缘(R1),并伴有或不伴有阳性切缘的修正。主要结果是总生存期(OS)。次要结果包括术后并发症风险。
共筛选出 449 项研究。纳入了 10 项回顾性观察研究,共报告了 1955 例患者。成功修正阳性近端和/或远端胆管切缘(R1R0)的患者与原发性切缘阴性切除(R0)的患者具有相似的 OS(风险比 [HR] 0.93,95%置信区间 [CI] 0.72-1.19,p = 0.56,I = 84%),并且明显优于最终胆管切缘阳性(R1)的患者(HR 0.52,95%CI 0.34-0.79,p = 0.002,I = 0%)。尽管术后发病率不一致,但与额外切除相关的术后并发症风险并未增加。
本综述支持在 PHC 切除术中常规进行术中胆管切缘评估,如果技术可行,则进行修正。